FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:1189 September 15, 2005 Number 11

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear

By David B. Resnik. 235 pp. Albany, State University of New York Press, 2004. $57.50 (cloth); $18.95 (paper). ISBN 0-7914-5931-4 (cloth); 0-7914-5932-2 (paper).

David B. Resnik begins Owning the Genome with a disclaimer: he considers himself to be a professor of philosophy and ethics, not an attorney or legal scholar. Resnik is noticeably more self-assured in chapters devoted to ethical arguments about DNA patents than in background chapters on scientific and legal issues. He addresses both deontological arguments (DNA patents are inherently moral or immoral) and consequentialist arguments (DNA patents are moral or immoral because of their consequences), but it is the consequentialist arguments, both pro and con, that Resnik ultimately thinks matter. Faced with uncertainty about the likely consequences of DNA patents, . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.